981
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Ferulic acid modification enhances the anti-oxidation activity of natural Hb in vitro

, , &
Pages 1191-1199 | Received 23 Jan 2018, Accepted 03 Mar 2018, Published online: 13 Mar 2018

References

  • Seifried E, Mueller MM. The present and future of transfusion medicine. Blood Transfus. 2011;9:371–376.
  • Modery-Pawlowski CL, Tian LL, Pan V, et al. Synthetic approaches to RBC mimicry and oxygen carrier systems. Biomacromolecules. 2013;14:939–948.
  • Chang TMS. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif Cells Blood Substit Immobil Biotechnol. 2012;40:197–199.
  • Winslow RM. Progress on blood substitutes. Nat Med. 1997;3:474.
  • Chang TMS. Blood substitutes: principles, methods, products and clinical trials. Switzerland: S. Karger AG; 1997.
  • Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergency surgery. J Am Coll Surg. 1998;187:113–122.
  • McCarthy MR, Vandegriff KD, Winslow RM. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem. 2001;92:103–117.
  • Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999;282:1857–1864.
  • Mullon J, Giacoppe G, Clagett C, et al. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med. 2000;342:1638–1643.
  • Sakai H, Cabrales P, Tsai AG, et al. Oxygen release from low and normal P50Hb vesicles in transiently occluded arterioles of the hamster window model. Am J Physiol. 2005;288:H2897–H2903.
  • Cabrales P, Sakai H, Tsai AG, et al. Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am J Physiol. 2005;288:H1885–H1892.
  • Jia Y, Duan L, Li J. Hemoglobin-based nanoarchitectonic assemblies as oxygen carriers. Adv Mater Weinheim. 2016;28:1312–1318.
  • Hosaka H, Haruki R, Yamada K, et al. Hemoglobin-albumin cluster incorporating a Pt nanoparticle: artificial O2 carrier with anti-oxidant activities. PLoS One. 2014;9:e110541.
  • Reiss JG. Oxygen carriers (“blood substitutes”)-raisond’etre, chemistry, and some physiology. Chem Rev. 2001;101:2797–2920.
  • D’Agnillo F, Alayash AI. Redox cycling of diaspirin cross-liked Hb induced G2/M arrest and apoptosis in cultured endothelial cells. Blood. 2001;98:3315–3323.
  • Naito Y, Fukutomi I, Masada Y, et al. Virus removal from hemoglobin solution using Planova membrane. Artif Organs. 2002; 5:141–145.
  • Nagababu E, Ramasamy S, Rifkind JM, et al. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry. 2002;41:7407–7415.
  • Winterbourn CC. Oxidative reactions of hemoglobin. Meth Enzymol. 1990;186:265–272.
  • Johnson RM, Goyette G, Jr, Ravindranath Y, et al. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med. 2005;39:1407–1417.
  • Wang MY, Yu YT, Chang TMS. New method for preparing more stable microcapsules for the entrapment of genetically engineered cells. Artif Cells Blood Subs Immob Biotech. 2005;33:257–269.
  • Gu J, Chang TMS. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase. Artif Cells Blood Subs and Biotech. 2009;37:69–77.
  • Alagic A, Koprianiuk A, Kluger R. Hb-superoxide dismutases-chemical linkages that create a dual-function protein. J Am Chem Soc. 2005;127:8036–8043.
  • Hathazi D, Mot AC, Vaida A, et al. Oxidative protection of hemoglobin and hemerythrin by cross-linking with a nonheme iron peroxidase: potentially improved oxygen carriers for use in blood substitutes. Biomacromolecules. 2014;15:1920–1927.
  • Schaer CA, Deuel JW, Bittermann AG, et al. Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage. Cell Death Differ. 2013;20:1569–1579.
  • Simoni J, Simoni G, Wesson DE, et al. ATP-adenosine-glutathione cross-linked hemoglobin as clinically useful oxygen carrier. Curr Drug Discovery Technol. 2012;9:173–187.
  • Ou S, Kwok KC. Ferulic acid: pharmaceutical functions, preparation and applications in foods. J Sci Food Agric. 2004;84:1261–1269.
  • Mathew S, Abraham T. Ferulic acid: an anti-oxidant found naturally in plant cell walls and feruloylesterases involved in its release and their applications. Crit Rev Biotechnol. 2004;24:59–83.
  • Guo S, Wang P, Chen C, et al. Processing of ferulic acid modified hemoglobin. Artif Cells Nanomed Biotechnol. 2016;44:1075–1079.
  • Walder RY, Andracki ME, Walder JA. Preparation of intramolecularly cross-linked hemoglobins. Meth Enzymol. 1994;231:274–280.
  • Riener CK, Kada G, Gruber HJ. Quick measurement of protein sulfhydryls with Ellman's reagent and with 4, 4'-dithiodipyridine. Anal Bioanal Chem. 2002;373:266–276.
  • Abugo OO, Rifkind JM. Oxidation of hemoglobin and the enhancement produced by nitroblue tetrazolium. J Biol Chem. 1994;269:24845–24853.
  • Chang TM. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 1971;44:1531–1536.
  • Winslow RM. Blood substitutes. Adv Drug Deliv Rev. 2000;40:131–142.
  • Rameez S, Alosta H, Palmer AF. Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier. Bioconjugate Chem. 2008;19:1025–1032.
  • Silverman TA, Weiskopf RB. Hemoglobin-based oxygen carriers: current status and future directions. Transfusion. 2009; 49:2495–2515.
  • Nicholson SK, Tucker GA, Brameld JM. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 2008;67:42–47.
  • Pimenova T, Pereira CP, Gehrig P, et al. Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin. J Proteome Res. 2010;9:4061–4070.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.